-
Mashup Score: 0Tweetorial 3: Not Just Another Monoclonal Antibody: Best Practices for Providing T-cell Therapies — Current Activities - 6 month(s) ago
Differentiating Bispecifics & CAR-T for Relapsed Refractory Multiple Myeloma Tweetorial 3: Not Just Another Monoclonal Antibody: Best Practices for Providing T-cell Therapies This activity is jointly provided by Global Education Group and Bonum…
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
#mmsm ↪️ Need on the who, what, where, how to provide #BCMA-directed T-cell tx for #Myeloma? 📚 Lots to learn w @mvmateos & me 👇#MedTweetorial🧵 🏆 🆓#CME 👉🏼https://t.co/q4DprzNF7G Supported by educational grants from @JanssenUS & @Pfizer 🏁What’s your specialty?
-
-
Mashup Score: 3HCM in IBD — Current Activities - 7 month(s) ago
Real-world Access to T cell-directed Therapies in Multiple Myeloma: Driving Away Health Disparities This activity is jointly provided by Global Education Group and Bonum CE. …
Source: Current ActivitiesCategories: Hematologists1, Latest HeadlinesTweet-
2/@BonumCE @Global_CME #mmsm ⚠️Important "need to know" items👇 1️⃣ - read CME ℹ️👉🏼https://t.co/W7S6rrN2FJ 2️⃣ - take the Pre-survey: https://t.co/vxR0PL3yeH 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/J2OJdRrcEP
-
Did u know incidence of #myeloma is >2️⃣x ⬆️in African American than in White ppl in🇺🇸? ☑️ out #mmsm Disparities & Access #MedTweetorial🧵w @MaiolinoAngelo & Me👋 🆓#CME 👉🏼 https://t.co/W7S6rrN2FJ Support by edu grants from @JanssenUS & @Pfizer 🏁First, what’s ur specialty?
-
-
Mashup Score: 0EC Tweetorial — Current Activities - 1 year(s) ago
In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
2/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer #MedTweetorial 🆓 CME > full info➕ref list🗒️& program archive 👉https://t.co/Nytez5VA4X 🔑#CME info👇 https://t.co/RgsUQiuEtg
-
-
Mashup Score: 0EC Tweetorial — Current Activities - 1 year(s) ago
In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
1/#OncTwitter #TumorBoardTuesday #MedTweetorial 🧵 ✅#EndometrialCancer AE deep dive🤿 🧪Trial results 🔬Tox for TKI-ICI w me, @MeganLeigh127 & @TumorBoardTues 🆓#CME @BonumCE🔗https://t.co/Nytez5VA4X Supported by edu grants from Eisai & @Merck 🟢What's your specialty?
-
-
Mashup Score: 0RCC Tweetorial — Current Activities - 1 year(s) ago
In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Renal Cell Carcinoma (RCC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
2/ #TumorBoardTuesday #BonumCE #RenalCell #OncTwitter #NephTwitter 🆓#CME info ➕ full ref list🗒️ 👉 https://t.co/mVFL8DtKHB ✳️The critical elements👇 https://t.co/OJroKioMrP
-
1/ #OncTwitter #NephTwitter #TumorBoardTuesday ✅#RenalCell #MedTweetorial🧵 w @brian_rini @shilpaonc @katy_beckermann 🦺TKI/IO safety data 🥽Tox to look 4 ⛑AE mgmt 🆓#CME @BonumCE🔗https://t.co/mVFL8DtKHB Support by edu grants from Eisai & @Merck 🟢What's your specialty?
-
2/ #TumorBoardTuesday #BonumCE #RenalCell #OncTwitter #NephTwitter 🆓#CME info ➕ full ref list🗒️ 👉 https://t.co/4GDYyhvhPS ✳️The critical elements👇 https://t.co/qqiIa7P4pg
-
1/ #OncTwitter #NephTwitter ✅#RenalCell #TumorBoardTuesday #MedTweetorial 🧵 w @brian_rini @shilpaonc @katy_beckermann 🦺TKI/IO safety data 🥽Tox to look 4 ⛑AE mgmt 🆓#CME @BonumCE🔗https://t.co/4GDYyhuK0k Support by edu grants from Eisai & @Merck 🟢What's your specialty?
-
-
Mashup Score: 7RSV Tweetorial 2 — Current Activities - 2 year(s) ago
This Twitter-based, CME-certified Tweetorial activity focuses on the symptom profile of Respiratory Syncytial Virus (RSV), symptom overlap with other respiratory tract infections, methods for detecting and confirming an RSV diagnosis; specifically reviewing available tests including specificity and
Source: Current ActivitiesCategories: Infectious Disease, Latest HeadlinesTweet-
15/ 💫Thanks for joining us & @MichaelGIsonMD, @HannahNamMD & @BonumCE 🏆 Earn your 🆓 #CME 🔗 https://t.co/lFA2EbD1xQ 🗳️Submit your answers to the post-polls below 👇
-
2/ #MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine 🟠Earn #CME 🏆on Twitter! 🟠Full CME ℹ️ 🔗https://t.co/lFA2EbD1xQ #BonumCE 📸 Faculty disclosures & important CME info 👇 https://t.co/5S20WszTpj
-
1/ 🕶️Coolest way 2 learn in summer ☀️ 😷 RSV #MedTweetorial series @MichaelGIsonMD & me review #RSV: 🚨 Why rapid ID❗️ 🤒 Sx profiles 🧪 Tests & Dx @BonumCE #CME 🔗https://t.co/lFA2EbD1xQ Support by edu grant from @JanssenUS 🔎 What’s ur specialty?
-
-
Mashup Score: 1RSV Tweetorial 1 — Current Activities - 2 year(s) ago
This CME-certified Tweetorial aims to close knowledge gaps and improve awareness of the significant morbidity and mortality caused by Respiratory Syncytial Virus (RSV) infection, especially in older adults. This short, Twitter-based activity will address RSV prevalence, shed light on the burden of R
Source: Current ActivitiesCategories: Infectious Disease, Latest HeadlinesTweet-
23/ 💫Thanks for joining us & @VargaLab, @HannahNamMD @BonumCE 📺Stay tuned for our review of #RSV testing + diagnostics on Fri. June 24 w/ @MichaelGIsonMD 🏆 Earn your 🆓 #CME 🔗 ▶️ https://t.co/LaZf3sQTCu 🗳️Submit your answers to the post-polls below 👇
-
3/ #MedTwitter #CME ➡️ https://t.co/LaZf3sQTCu 🔍Let’s explore #RSV: an under-recognized problem! 🚩RSV = Respiratory Syncytial Virus 🚩Enveloped single-stranded RNA virus 🚩Common cause of acute respiratory infections (ARIs) 2️⃣ genotypes (RSV-A & RSV-B) usually predominate https://t.co/HWfYhDqcIQ
-
2/ #MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine 🟠Earn #CME 🏆 w just 23 tweets 🟠Full CME ℹ️ 🔗https://t.co/LaZf3sQTCu 📸 Faculty disclosures & important CME info 👇 https://t.co/oNKLaAXkOW
-
1/ ⛱️Kick back & relax while learning 🔖w #RSV #MedTweetorial series Me & @VargaLab review #epidemiology + burden of respiratory syncytial virus 🫁 @BonumCE 🏆🆓#CME 🔗▶️ https://t.co/LaZf3sQTCu Supported by edu grant from @JanssenUS 🔎 What’s your specialty?
-
-
Mashup Score: 1Multiple Myeloma Biomarkers — Current Activities - 2 year(s) ago
In this CME-certified, Twitter-based activity, we will explore outcomes for patients with RRMM, including health disparities that impact mortality, mortality trends and predictors of survival, and triple-class refractory disease.
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
@jmikhaelmd @BonumCe @JanssenUS @pfizer 2/ 🎇🆓 AMA PRA Credit 🎇 CME ℹ️ & ref list👉 https://t.co/0NV1dHogta 🗝️ Disclosure info 👇 #BonumCE #MMSM https://t.co/n906L4M6We
-
1/ 📣 #hematology & #oncology HCPs R u 🤔 about soluble BMCA (sBMCA)? ⁉️ Haven't heard of sBCMA? 🥷 @End_myeloma saves the day w #MedTweetorial 🧵 w @BonumCe 🆓 #CME 📲 https://t.co/6lVdrHZ0MH Supported by edu grants from @janssenUS @pfizer 🔰What's your specialty? 👇
-
-
Mashup Score: 7MM BMCAs Tweetorial #2 — Current Activities - 2 year(s) ago
Not All BCMAs Are Created Equal:Mechanisms of action of BCMA-directed therapies This activity is jointly provided by Global Education Group and Bonum CE. …
Source: Current ActivitiesCategories: Hem/Oncs, Latest HeadlinesTweet-
@ninashah33 @rajshekharucms @RahulBanerjeeMD @bdermanmd @HiraSMian @IMFmyeloma @jmikhaelmd @DrOlaLandgren @szusmani @JackMAiello @mtmdphd @Mohty_EBMT @BldCancerDoc @myelomaMD @End_myeloma @Ccostello7 16/ 🙌Thanks from me @ninashah33 & @BonumCE for participating #MedTweetorial 🆓#CME https://t.co/cMDMrUjjo1 🔗Credit 👉 https://t.co/xa1IQlUZMW 🚨Don't forget 👇 Posttest Q 1️⃣ 📊 Which of the following best describes 1 way overexpression of BCMA promotes development of MM ?
-
2/@rajshekharucms @rahulbanerjeeMD @bdermanmd @hiraSmian @IMFMyeloma @jmikhaelMD @DrOlaLandgren @szusmani @JackMAiello @mtmdphd @Mohty_EBMT @BldCancerDoc @myelomaMD #mmsm #BonumCE 🆓CME 👉https://t.co/kC32xDRjpw Full ref 🗒️👉 https://t.co/wVJH11bHN3 ℹ️The critical elements👇 https://t.co/448REm7s03
-
1/📣 #Hematology #OncTwitter HCPs 🧐Curious about how #BCMA therapies work? 🧩How they differ? 🆙1st @SurbhiSidanaMD ✅#mmsm #MedTweetorial 🧵 🆓#CME 🔗 https://t.co/kC32xDRjpw Supported by edu grants from @janssenUS @pfizer Provided by @BonumCe 📊 What's your specialty?
-
-
Mashup Score: 3HCM in IBD — Current Activities - 2 year(s) ago
Changing the Narrative: Outcomes of Patients with Multiple Myeloma This activity is jointly provided by Global Education Group and Bonum CE. …
Source: Current ActivitiesCategories: Hematologists1, Latest HeadlinesTweet-
1/ 📣 #hemonc #OncTwitter HCPs ❔Do u 🤔: 🧩State of #MultipleMyeloma 🧩 Evolution & 🔮 tx 🆕 #MMSM #MedTweetorial 🧵 w/ 👩🏫@SurbhiSidanaMD on deck 🆓#CME 🔗https://t.co/LoNvD68GGG Supported by edu grants from @janssenUS @pfizer Provided by @BonumCe 📊 What's ur specialty?
-
2/#MMsm @BonumCE @Global_CME ⚠️Important "need to know" items👇 1️⃣ - read CME ℹ️👉🏼https://t.co/q4DprzNF7G 2️⃣ - take the Pre-survey: https://t.co/1vp73c6uUt 3️⃣ - get all the info 👇 4️⃣ - claim your #CME 🏆 https://t.co/BITxNCTzHW